产品名称 | 产品编号 | 浓度/详细参数 | CAS号 | 规格/计量单位 | 价格 | 货期 | 品牌 |
---|---|---|---|---|---|---|---|
AF40431 | A649655-10mg | ≥98% | 181125-92-8 | 10mg | ¥ 5500.9 | 期货,请咨询 | 阿拉丁 |
AF40431 | A649655-100mg | ≥98% | 181125-92-8 | 100mg | ¥ 22500.9 | 期货,请咨询 | 阿拉丁 |
Artemisitene | A649643-5mg | ≥98% | 101020-89-7 | 5mg | ¥ 2500.9 | 期货,请咨询 | 阿拉丁 |
Artemisitene | A649643-25mg | ≥98% | 101020-89-7 | 25mg | ¥ 6800.9 | 期货,请咨询 | 阿拉丁 |
Artemisitene | A649643-1mg | ≥98% | 101020-89-7 | 1mg | ¥ 952.9 | 期货,请咨询 | 阿拉丁 |
Artemisitene | A649643-10mg | ≥98% | 101020-89-7 | 10mg | ¥ 3800.9 | 期货,请咨询 | 阿拉丁 |
ABC1183 | A649618-5mg | 1042735-18-1 | 5mg | ¥ 900.9 | 期货,请咨询 | 阿拉丁 | |
ABC1183 | A649618-50mg | 1042735-18-1 | 50mg | ¥ 4800.9 | 期货,请咨询 | 阿拉丁 | |
ABC1183 | A649618-25mg | 1042735-18-1 | 25mg | ¥ 3000.9 | 期货,请咨询 | 阿拉丁 | |
ABC1183 | A649618-10mg | 1042735-18-1 | 10mg | ¥ 1440.9 | 期货,请咨询 | 阿拉丁 | |
ABC1183 | A649618-100mg | 1042735-18-1 | 100mg | ¥ 7680.9 | 期货,请咨询 | 阿拉丁 | |
β-Amyloid (1-16) | A649616-5mg | ≥99% | 131580-10-4 | 5mg | ¥ 3900.9 | 期货,请咨询 | 阿拉丁 |
β-Amyloid (1-16) | A649616-1mg | ≥99% | 131580-10-4 | 1mg | ¥ 1100.9 | 期货,请咨询 | 阿拉丁 |
Alogabat | A649594-5mg | ≥99% | 2230009-48-8 | 5mg | ¥ 4000.9 | 期货,请咨询 | 阿拉丁 |
Alogabat | A649594-10mg | ≥99% | 2230009-48-8 | 10mg | ¥ 6100.9 | 期货,请咨询 | 阿拉丁 |
Alisol F | A649576-5mg | ≥99% | 155521-45-2 | 5mg | ¥ 1850.9 | 期货,请咨询 | 阿拉丁 |
Alisol F | A649576-1mg | ≥99% | 155521-45-2 | 1mg | ¥ 845.9 | 期货,请咨询 | 阿拉丁 |
Alisol F | A649576-10mg | ≥99% | 155521-45-2 | 10mg | ¥ 3500.9 | 期货,请咨询 | 阿拉丁 |
Anisatin | A649575-5mg | ≥98% | 5230-87-5 | 5mg | ¥ 4350.9 | 期货,请咨询 | 阿拉丁 |
Anisatin | A649575-10mg | ≥98% | 5230-87-5 | 10mg | ¥ 7800.9 | 期货,请咨询 | 阿拉丁 |
AVG-233 | A649547-5mg | ≥98% | 2151937-80-1 | 5mg | ¥ 4000.9 | 期货,请咨询 | 阿拉丁 |
AVG-233 | A649547-25mg | ≥98% | 2151937-80-1 | 25mg | ¥ 13500.9 | 期货,请咨询 | 阿拉丁 |
AVG-233 | A649547-10mg | ≥98% | 2151937-80-1 | 10mg | ¥ 6800.9 | 期货,请咨询 | 阿拉丁 |
ADRA1D receptor antagonist 1 | A649539-5mg | ≥98% | 1191908-14-1 | 5mg | ¥ 4800.9 | 期货,请咨询 | 阿拉丁 |